These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6302127)

  • 21. Human mutation affecting hormone-sensitive adenylate cyclase.
    Bourne HR; Farfel Z; Brickman AS; Kaslow HR; Brothers VM
    Prog Clin Biol Res; 1981; 63():433-7. PubMed ID: 6273928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism: biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds.
    Levine MA; Jap TS; Mauseth RS; Downs RW; Spiegel AM
    J Clin Endocrinol Metab; 1986 Mar; 62(3):497-502. PubMed ID: 3003142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal adenylate cyclase and the interrelationship between parathyroid hormone and vitamin D in the regulation of urinary phosphate and adenosine cyclic 3',5'-monophosphate excretion.
    Forte LR; Nickols GA; Anast CS
    J Clin Invest; 1976 Mar; 57(3):559-68. PubMed ID: 175088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma cyclic nucleotide determination in the investigation of hypocalcemia.
    Mallet E; Basuyau JP; Brunelle P; de Menibus CH
    Pediatr Res; 1979 May; 13(5 Pt 1):647-8. PubMed ID: 224372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolactin and calcitonin responses to parathyroid hormone infusion in hypoparathyroid, pseudohypoparathyroid, and normal subjects.
    Brickman AS; Carlson HE; Deftos LJ
    J Clin Endocrinol Metab; 1981 Sep; 53(3):661-4. PubMed ID: 7263847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence that parathyroid hormone-mediated calcium transport in rat brain synaptosomes is independent of cyclic adenosine monophosphate.
    Fraser CL; Sarnacki P; Budayr A
    J Clin Invest; 1988 Apr; 81(4):982-8. PubMed ID: 2832450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A new technic to evaluate the sensitivity of the renal parathyroid hormone receptor in man].
    Mallet E; de Menibus CH; Basuyau JP; Brunelle P
    C R Seances Soc Biol Fil; 1976; 170(5):1094-8. PubMed ID: 192424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-receptor responsiveness after desipramine treatment.
    Pohl R; Pandey GN; Yeragani VK; Balon R; Davis JM; Berchou R
    Psychopharmacology (Berl); 1993; 110(1-2):37-44. PubMed ID: 7870896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity.
    Farfel Z; Brothers VM; Brickman AS; Conte F; Neer R; Bourne HR
    Proc Natl Acad Sci U S A; 1981 May; 78(5):3098-102. PubMed ID: 6265935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of catecholamines and adrenergic-blocking agents on plasma and urinary cyclic nucleotides in man.
    Ball JH; Kaminsky NI; Hardman JG; Broadus AE; Sutherland EW; Liddle GW
    J Clin Invest; 1972 Aug; 51(8):2124-9. PubMed ID: 4403383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of parathyroid hormone on 1,25-dihydroxyvitamin D formation in type I pseudohypoparathyroidism.
    Aksnes L; Aarskog D
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1223-6. PubMed ID: 6255001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Plasma 1.25 (OH)2D and PTH levels and urinary cyclic AMP response to exogenous PTH in PHP during childhood (author's transl)].
    Seino Y; Ishida M; Shimotsuji J; Ishii T; Matsuda S
    Horumon To Rinsho; 1979 Aug; 27(8):879-84. PubMed ID: 226296
    [No Abstract]   [Full Text] [Related]  

  • 33. [The diagnostic value of the determination of cyclic 3',5'-adenosine monophosphate (cAMP) in urine].
    Gennari C; Galli M; Montagnani M; D'Amore I
    Quad Sclavo Diagn; 1976 Mar; 12(1):15-38. PubMed ID: 190633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pseudohypoparathyroidism. Disease of the second messenger].
    Stögmann W
    Fortschr Med; 1976 Oct; 94(29):1638-40. PubMed ID: 186374
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolution of pseudohypoparathyroidism: an informative family study.
    Barr DG; Stirling HF; Darling JA
    Arch Dis Child; 1994 Apr; 70(4):337-8. PubMed ID: 8185370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cyclic-AMP response to parathyroid hormone in Turner's syndrome and Albright's hereditary osteodystrophy.
    Ashby JP; Renton WB; MacPherson JN; Price WH; Abbott SR
    Clin Endocrinol (Oxf); 1979 Jun; 10(6):553-6. PubMed ID: 225067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for normal antidiuretic responses to endogenous and exogenous arginine vasopressin in patients with guanine nucleotide-binding stimulatory protein-deficient pseudohypoparathyroidism.
    Moses AM; Weinstock RS; Levine MA; Breslau NA
    J Clin Endocrinol Metab; 1986 Jan; 62(1):221-4. PubMed ID: 2999179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart rate and plasma cyclic AMP responses to isoproterenol infusion and effect of beta-adrenergic blockade in patients with postural orthostatic tachycardia syndrome.
    Abe H; Nagatomo T; Kohshi K; Numata T; Kikuchi K; Sonoda S; Mizuki T; Kuroiwa A; Nakashima Y
    J Cardiovasc Pharmacol; 2000; 36 Suppl 2():S79-82. PubMed ID: 11206727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthetic human parathyroid hormone-(1-34) for the study of pseudohypoparathyroidism.
    Mallette LE; Kirkland JL; Gagel RF; Law WM; Heath H
    J Clin Endocrinol Metab; 1988 Nov; 67(5):964-72. PubMed ID: 2846629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pseudohypoparathyroidism type I and vitamin D therapy].
    Kovarik J; Weissel M; Neuwirth G; Krepler P; Willvonseder R
    Acta Med Austriaca; 1978; 5(3):106-9. PubMed ID: 222102
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.